Takeda speeds narcolepsy drug to late-stage testing
BioPharma
Stay updated with breaking news from Alkermes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DUBLIN, Feb. 8, 2024 /PRNewswire/ -- Alkermes plc will host a conference call and webcast presentation at 8:00 a.m. ET on Thursday, Feb. 15, 2024 to discuss the company's fourth quarter and...
Our January 2024 psychiatry month in review includes studies finding associations with depression, anxiety, and anorexia nervosa, as well as a phase 3 study looking into long-term safety of olanzapine, samidorphan.
These pivotal biotech stocks for gains are charting the future of medicine and investment growth in 2024 offering powerful returns
Here are some updates from the world of psychiatry throughout the month of January.